Abstract
Surfactant protein C (SP-C) is one of four surfactant proteins produced by type II pneumocytes. Mutations in surfactant protein A are strongly associated with development of lung cancer. Mutations in the SP-C gene are rare and are associated with interstitial lung disease in the pediatric age group. We describe two patients with SP-C mutations who developed lung cancer. Both patients had concurrent interstitial lung disease, although the clinical phenotype was variable. In both cases, mutations were in translated region of the SP-C gene; one in the BRICHOS domain and the other in the transmembrane domain. Our paper suggests that patients with SP-C mutations can be at increased risk for the development of lung cancer, and it's reasonable to follow them routinely.
Original language | English |
---|---|
Article number | 100461 |
Journal | Cancer Treatment and Research Communications |
Volume | 29 |
DOIs | |
State | Published - Jan 2021 |
Bibliographical note
Publisher Copyright:© 2021
Keywords
- Adenocarcinoma
- Lung cancer
- SP-C
- Surfactant